RespireRx Pharmaceuticals Inc (RSPI)

[myostrain]

It would always be a pleasant surprise for RD results to be let out ahead of schedule and be positive, along with a deal before or after RD results which solidifies the cashflow.

That being said, what would the royalty range be in?
If Greers company goes public, what is their pipeline and cash sources and expenses, and what is the growth potential of that company. I really doubt they would develop any significant products unless there were combination products involved and in that arena I would hope Cortex would have the main royalty.
I would lean towards the viability of Greer's company depends on their agreement with Cortex and as an investor in Cortex I hope the royality is minimal and view Greer's company as what neuro has stated and hopefully a company of small infrastructure.

If the deal with Greer's company has an above average royalty involved, and also if Cortex has deals with different BPs, the potential for Cortex's investors becomes squeezed more and more.